February 9th, 2010 by Elizabeth Kissling
There are Tupperware parties, Passion Parties, Pampered Chef parties, and…Mirena IUD parties? Yes, apparently these events popped up early last year and were a joint effort from Bayer Pharmaceuticals and the mom marketing site Mom Central.
Here’s one mom blogger’s description of the Mirena party that she hosted:
Then tonight I hosted a party at my house with Mom Central. Mom Central had found me through this blog and asked me if I would be interested in hosting an event sponsored by Mirena. As I welcome any opportunity to sit down with some girlfriends with some free food and drink, I was happy to accept. Before the party started, I walked around nervously, terrified that only a couple of people would show up. We’re all so busy, and I worried that people would end up skipping a strange commercial-sounding event. But one by one, they rolled in and I began to relax.
We had an amazing evening, talking about sex, fashion, and living a simpler life. I realized that we don’t actually spend a lot of time talking about sex and relationships. We laughed a lot but also went home with some great tips.
Continue reading...
Tags: advertising, big pharma, Birth Control, blogging, drugs, economics, government agencies, guest post, IUD
Posted in Advertising, Birth Control, Law/Legal, Pharmaceutical | 3 Comments »
January 25th, 2010 by Elizabeth Kissling
Tags: advertising, big pharma, birth control pill, FemCare advertising, Humor, internet, period control, viral video
Posted in Birth Control, FemCare, Humor, Internet, Media, Menstruation | 2 Comments »
December 18th, 2009 by Elizabeth Kissling
You may have heard the news that 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer were dismissed by a New York judge this week. Judge Martin Shulman granted Pfizer’s motion to dismiss for two reasons: the plaintiff’s delayed filing exceeded the the three-year statute of limitations in New York, and that “the potential risk of contracting breast cancer from taking HRT medication was well known at all times out there in the stream of public information.” Oddly, Judge Shulman simultaneously asserted “that the debate over HRT health problems has not yet been settled.”
I can’t argue about exceeding the statute of limitations, but it’s difficult for a judge to assert that breast cancer risk of hormone therapy is well known public information. The Lancet reported today that up to half of US adults have trouble interpreting medical information, displaying low levels of health literacy. Health literacy, according to The Lancet, is the ability to comprehend and use medical information that can affect access to and use of the health-care system. Health literacy is more than reading and comprehending news reports of medical issues (which are often of poor quality – see Health News Review for sharp analysis of health news); one must also know how to navigate the complexities of the health care system, including knowing how and when to question one’s physicians and pharmacists. Continue reading...
Tags: advertising, big pharma, breast cancer, drugs, government agencies, Health Care, hormones, lawsuit, Menopause
Posted in Health Care, Law/Legal, Menopause, Pharmaceutical | 1 Comment »
December 16th, 2009 by Elizabeth Kissling
Tags: big pharma, breast cancer, hormones, lawsuit, Menopause, Prempro, viral video
Posted in Internet, Law/Legal, Media, Menopause, Pharmaceutical | Comments Off
December 13th, 2009 by Elizabeth Kissling
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of Wyeth’s advertising campaigns, the article mentions the firm’s contract with DesignWrite, a company drug makers pay to develop manuscripts for publication in medical journals, to prepare at least 60 articles for publication in medical journals on the potential benefits of hormone therapy for cardiovascular disease, Alzheimer’s disease, diabetes, colon cancer, vision loss and other health problems.
The article also includes access to PDFs of some of the thousands of pages of documents from Wyeth that were requested by plaintiffs in the lawsuits against the drug manufacturer. (To date, more than 13,000 people have sued Wyeth claiming that they developed breast cancer and other health problems after taking the company’s menopausal hormone drugs. As we reported three weeks ago, in ten of the twelve verdicts so far, juries have awarded significant sums to plaintiffs. ) The documents available at the New York Times include a publication plan for Wyeth from DesignWrite, a 1995 product launch speech from Wyeth’s marketing director proclaiming the company’s mission of bringing to fruition Dr. Bernadine Healy’s vision of “a world in which the vast majority of women would begin taking HRT, and we know that means Prempro, at menopause and continue on for the rest of their lives.” There’s also this handwritten note from a 1996 meeting about how to respond to a new study raising breast cancer concerns (red markings added by me): Continue reading...
Tags: advertising, big pharma, breast cancer, drugs, economics, hormones, lawsuit, Menopause
Posted in Advertising, Law/Legal, Media, Menopause | 2 Comments »
December 11th, 2009 by Elizabeth Kissling
Tags: big pharma, boys/men, breast cancer, drugs, economics, Girls, Health Care, lawsuit
Posted in Girls, Health Care, Law/Legal, New Research, Pharmaceutical | 2 Comments »
November 25th, 2009 by Elizabeth Kissling
re:Cycling readers may be interested in this story in the current issue of Macleans about the declining interest in oral contraceptives among Canadian women, particularly among women in their 20s who’ve been using The Pill for a decade.
[O]ral contraceptive prescriptions in Canada levelled off in 2008, reports pharmaceutical industry analyst IMS Health Canada. Health care workers are seeing a growing demand for non-hormonal methods. Spurred by concerns about their health, the environment, or even frustration with family doctors, who sometimes seem to push the pill as a modern-day cure-all, Canadian women are looking for other options.
The report echoes a couple of recent discussions here at re:Cycling, such as our guest post from Holly Grigg-Spall and Laura Wershler’s response, guest post from Moira Howe about the quiescent uterus, and discussion of risks of YAZ.
And Dr. Jerilynn Prior, scientific director of the Centre for Menstrual Cycle and Ovulation Research (and past president of the Society for Menstrual Cycle Research) is quoted in the article: “There’s an emotional identity attached to achieving your own menstrual cycle, and being able to read your body,” she says. “When you’re on the pill, it’s the doctor who’s controlling your cycle. You don’t own it.”
It’s good to see this issue getting some attention in mainstream media.
[via Sexual Health Access Alberta]
Tags: big pharma, birth control pill, hormones
Posted in Birth Control, Menstruation, Pharmaceutical, magazines, ovulation | 2 Comments »
November 23rd, 2009 by Elizabeth Kissling
There are more than 10,000 lawsuits against Wyeth/Pfizer regarding the link between PremPro and breast cancer. There have been 12 verdicts so far, and juries have awarded money to the plaintiffs in ten of those cases. The latest was announced today, in Donna Kendall v. Wyeth (Phila. CCP, June Term, 2004, No. 0965). The jury awarded Ms. Kendall $6.3 million in compensatory damages, and $28 million in punitive damages.
So far, thirteen women have settled their claims with Wyeth/Pfizer, but if awards like these continue, can we expect Pfizer soon to be offering to settle the rest?
The film clip at left is a video press release prepared by Littlepage Booth, the Houston law firm that represented both Connie Barton and Donna Kendall in their claims against Wyeth/Pfizer.
Tags: big pharma, breast cancer, lawsuit, Menopause, Prempro
Posted in Law/Legal, Menopause, Pharmaceutical | 2 Comments »
November 9th, 2009 by Elizabeth Kissling
Guest Post by Holly Grigg-Spall, freelance writer (”Sweetening the Pill“)
The popularity of the birth control pill is an essential element of our cultural attitude towards menstruation, and women’s bodies as a whole. After taking the pill for ten years I recently decided to stop, for good. I have this month had my first real period in a decade. I didn’t decide to come off the pill because I want a baby, it’s because I want to blog, and have been blogging about the pill for several months. My blog ranges from my own personal ramblings about taking the pill, to adventures in the world of women’s studies. I am not religious, pro-abstinence or anything like a hippy, I just came to realise that I was taking a very powerful medication every day and I wasn’t sure exactly why. Continue reading...
Tags: big pharma, birth control pill, guest post, health, withdrawal symptoms
Posted in Birth Control, Pharmaceutical | 19 Comments »
October 27th, 2009 by Elizabeth Kissling
Connie Barton, an Illinois woman who developed breast cancer after taking Prempro for menopausal symptoms, was awarded punitive damages by a jury in Philadelphia yesterday. The jury has already awarded her $3.7 million in compensatory damages, back in September, but we will not learn the amount of punitive damages until another Philadelphia jury reaches their verdict in similar case against the Pfizer, the drug’s manufacturer. (Technically, the case was filed against Wyeth, but the two companies just completed a merger deal last week, and Wyeth is now a subsidiary of Pfizer.)
Wyeth’s attorneys successfully argued that public revelation of the amount of damages might influence the jurors in Kendall v. Wyeth. However, the jury’s finding that Wyeth ignored evidence that the drug could cause cancer is now public information. Would I sound bitter if I said I hope that news influences potential jurors?
According to the news story about Barton’s case at philly.com, Pfizer has now lost five of eight trials over its hormone-replacement drugs since cases began reaching juries in 2006. 1500 more trials against Wyeth are pending at the Philadelphia Court of Common Pleas. But a longer story in Philadelphia Magazine reports 23 out of 31 cases set for trial have been resolved favorably for Wyeth; the company has settled five, and several are on appeal. Continue reading...
Tags: big pharma, breast cancer, lawsuit, Menopause, Prempro
Posted in Law/Legal, Menopause, Pharmaceutical | Comments Off
Readers should note that statements published in re: Cycling are those of individual authors and do not necessarily reflect the positions of the Society as a whole.
RSS 
